T5	Limitation 50338 50340	We
T6	Limitation 52848 52850	In
T10	OTHER 54418 54499	This pilot trial involved co-funding and participation by the device manufacturer
#1	AnnotatorNotes T10	Funder involvement
T11	StudyTeam 55997 56027	the lack of clinician blinding
T12	Limitation 55960 55963	One
T13	Limitation 54418 54422	This
T8	PrecisionOfMeasurement 56563 56704	there was a difference in the reference time period for QVAS at baseline compared with the reference period used at the follow-up time-points
T9	Intervention 56960 57010	technical limitations of the ViMove motion-sensors
T14	Generalization 57574 57748	the applicability of the results outside of the research context is constrained by the need for clinicians to be trained in the use of the ViMove system and have access to it
T15	Limitation 57565 57572	However
T16	Limitation 56878 56880	We
T17	Limitation 56550 56552	In
T1	RelevantOutcomeExcluded 50338 50381	We did not collect the data to analyse this
T2	StudyTeam 52387 52470	It would also be ideal if recruitment were not performed by the treating clinicians
T3	Limitation 52387 52389	It
T4	Patient 52861 52989	it would be helpful to measure whether patients guessed which group they were allocated to, as an estimate of patient unblinding
